| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |